Abstract

Medicine representation learning which aims at uncovering hidden medicine relationships has emerged as a significant technique to imitate a doctor's cognitive reasoning process. The majority of present research focuses on the intuitive relationships between medication and diagnosis, however, ignores the inherent properties of medicines. This study uses a heterogeneous graph convolutional network (HGCN) and a spectral clustering (SC) algorithm to investigate the associated knowledge underlying clinical treatment. Based on the chronic obstructive pulmonary disease (COPD) clinical data, we construct a medicine-property heterogeneous network consisting of two types of nodes involving medicines and their properties, and three types of edges referring to the inter-medicine, inter-property, and medicine-property relations. HGCN is used to aggregate the neighbor nodes' information and then generalize the medicine and property embeddings. Then, SC is leveraged to divide these embeddings into the syndromes to which they belong. To verify the model performance, a series of experiments referring to the baseline comparison, ablation study, and parameter sensitivity test have been carried out. Compared to three baseline models and their variants on six evaluation metrics, the experimental results demonstrate that the HGCN-SC model outperforms the baseline approaches in medicine combination identification and has around 3.0% improvement in accuracy over the SC.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.